Skye Bioscience, Inc. Class of Warrant or Right, Outstanding
Skye Bioscience, Inc. (SKYE) had Class of Warrant or Right, Outstanding of 0 shares as of 2023-02-16, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2023-11-14
- 2023-02-16: Class of Warrant or Right, Outstanding 0.00 shares.
- 2014-09-30: Class of Warrant or Right, Outstanding 4.00M shares.
- 2013-12-31: Class of Warrant or Right, Outstanding 3.00M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-02-16 | 0.00 shares 10-Q · filed 2023-11-14 |
| 2014-09-30 | 4.00M shares 10-Q · filed 2014-11-14 |
| 2013-12-31 | 3.00M shares 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |